Unknown NA INTERVENTIONAL 2-arm NCT05165875

Splint Versus Steroid Randomized Trial

Splint Versus Steroid Injection for DeQuervain's Tenosynovitis: A Randomized Trial

Sponsor: National University Hospital, Singapore

Interventions Hydrocortisone-Lidocaine Splint

Updated 6 times since 2022 Last updated: Mar 7, 2022 Started: Jun 30, 2022 Primary completion: Feb 29, 2024 Completion: Feb 29, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on De Quervain Syndrome, this trial is ongoing. The trial is conducted by National University Hospital, Singapore and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Apr 2022 — Mar 2024 [monthly]

Not Yet Recruiting NA
Feb 2022 — Apr 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2022 — Feb 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University Hospital, Singapore

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.